secwatch.observer — SEC 8-K summary
======================================

Issuer:     Candel Therapeutics, Inc. (CADL)
CIK:        0001841387
Form:       8-K
Filed at:   2024-05-30T23:59:59+00:00
Accession:  0000950170-24-066608
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Candel Therapeutics reduces stockholder meeting quorum threshold to one-third
-----------------------------------------------------------------------------

- Board approved amendment to bylaws, effective May 29, 2024.
- Quorum requirement lowered from majority to one-third of shares entitled to vote.
- Amendment applies to all stockholder meetings of Candel Therapeutics, Inc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841387/000095017024066608/0000950170-24-066608-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841387/000095017024066608/cadl-20240529.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-066608

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer